Kus, D

The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on the Henry Ford Health System. [electronic resource] - Managed care interface 2001 - 21-3 p. digital

Publication Type: Journal Article

1096-5645


Anti-Ulcer Agents--economics
Decision Making, Organizational
Delivery of Health Care, Integrated--economics
Drug Costs
Enzyme Inhibitors--economics
Formularies as Topic
Gastroesophageal Reflux--drug therapy
Humans
Institutional Management Teams
Michigan
Organizational Policy
Proton Pump Inhibitors